Pancreatic Neuroendocrine Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-01-10
Clinical Trial Update: A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Clinical study evaluating the combination of sorafenib and gefitinib for pancreatic neuroendocrine neoplasm is currently recruiting.